FIGURE

FIGURE 1

ID
ZDB-FIG-210320-8
Publication
Paudel et al., 2021 - Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model
Other Figures
All Figure Page
Back to All Figure Page
FIGURE 1

Pictorial representation of experimental procedure. The figure depicts the several time points (at day 1 and day 10) in the corresponding experimental groups where treatments were performed with VC, Pilo, PTZ, DZP and three doses of mAb. In day 1 and day 10, there is a recording of locomotor behavior for 15 min for each experimental group. On day 10, in the DZP groups and mAbs groups, pre-treatment was done 30 min prior to PTZ administration. Starting from day 10, T-maze test were performed for each group at the interval of 0h, 3h and 24 h. After 24 h T-maze test, all the fish were euthanized, and brain samples were collected which were further subjected to biochemical investigations. D1, Day 1; D10, Day 10, D11, Day 11; VC, Vehicle control (10% DMSO, I.P.); DMSO, dimethyl sulfoxide; I.P., Intraperitoneal; Pilo, Pilocarpine (400 mg/kg, I.P.); PTZ, Pentylenetetrazol (80 mg/kg, I.P.); DZP, Diazepam (1.25 mg/kg, I.P.); mAb 1, Anti-HMGB1 mAb (1 mg/kg, I.P.); mAb 2.5, Anti-HMGB1 mAb (2.5 mg/kg, I.P.); mAb 5, Anti-HMGB1 mAb (5 mg/kg, I.P.).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Pharmacol